why choose us

First received: March 13, 2023

Clinical Trial: Real World Evidence Study in Subjects With Wilson's Disease

Study Status: Completed

Recruit Status: RECRUITING

Condition: Wilson Disease

Study Type: OBSERVATIONAL


Official Title: RWE Study of Subjects With Wilson's Disease to Assess Clinical Utility of Measuring Copper Parameters, Including a Novel Non-ceruloplasmin Bound Copper Assay Based on Copper Protein Speciation (N

Brief Summary: This non-interventional Real-World Evidence (RWE) study aims to describe non-ceruloplasmin copper values obtained using a new NCC Speciation assay by taking a small (up to 10mLs) volume of additional blood from patients with Wilson's Disease, around the time when routine blood sampling is expected to be scheduled by the treating physician.Data will be collected over an approximate 12-month period.

Read more